How accurate at-home flu tests are depends less on the brand printed on the box than on two things: the technology inside it and how soon after your first symptom you swab. Positive results are usually trustworthy. Negative results are where the trouble starts.
Most over-the-counter flu tests are antigen tests. They are cheap, fast, and — in the wrong circumstances — wrong with total confidence.
At-Home Flu Test Accuracy: Where Antigen Tests Lose Ground
Here is how the numbers stack up.
| Test Or Standard | Flu Sensitivity Vs. RT-PCR | Result Time |
|---|---|---|
| Rapid antigen test, read by eye | About 53–54% | 10–15 minutes |
| Rapid antigen test, CDC overall estimate | About 50–70% | 10–15 minutes |
| Rapid antigen test with digital reader | About 76–80% | 10–15 minutes |
| FDA clearance minimum for antigen flu tests | 80% | — |
| Rapid molecular assay | 66–100% | 15–30 minutes |
| Lucira by Pfizer test, influenza A | 90% | About 30 minutes |
| Lucira by Pfizer test, SARS-CoV-2 | 88.3% | About 30 minutes |
If you would rather compare specific kits before buying, our breakdown of the at-home flu tests worth buying covers what each one detects and who it fits.
Does Testing Too Early Give You A False Negative?
Yes. Swab too soon or too late and the sample can come back negative with influenza still in your system.
Technique matters nearly as much as timing. A swab that never presses against the walls of both nostrils collects less virus than the test needs.
Incomplete mixing or a vial that never seats can spoil the run.
Reading A Positive Or Negative Result
A positive antigen result is dependable; a negative one is not. The CDC recommends confirmatory molecular testing such as RT-PCR when a rapid test comes back negative but symptoms and exposure history still point to influenza, especially when community flu activity is high.
Prevalence flips the math the other way. When influenza is scarce — early fall, late spring, outside the season — a positive antigen result is more likely to be a false positive, because even a small error rate produces false hits in a population that mostly does not have the virus.
Detecting viral RNA is not the same as being contagious — a molecular test can register genetic material left over after your immune system cleared the infection.
For the Lucira by Pfizer test, the FDA labeling calls negative SARS-CoV-2 and influenza B results presumptive, which means they may need confirmation from a molecular test run in a qualified CLIA lab. Cleveland Clinic